Cargando…

The IL-33/sST2 Axis in Thromboangiitis Obliterans

BACKGROUND: Until recently, it remains unknown whether thromboangiitis obliterans (TAO) is a type of systemic vasculitis. A high level of IL-33 and its soluble decoy receptor sST2 in the acute phase of systemic vasculitis has been demonstrated. METHODS: The serum level of IL-33 and sST2 in 50 TAO pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharebiani, Hiva, Mohareri, Mehran, Mirhosseini, Ali, Fazeli, Bahare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371438/
https://www.ncbi.nlm.nih.gov/pubmed/32765040
http://dx.doi.org/10.2147/JIR.S253980
_version_ 1783561120942915584
author Sharebiani, Hiva
Mohareri, Mehran
Mirhosseini, Ali
Fazeli, Bahare
author_facet Sharebiani, Hiva
Mohareri, Mehran
Mirhosseini, Ali
Fazeli, Bahare
author_sort Sharebiani, Hiva
collection PubMed
description BACKGROUND: Until recently, it remains unknown whether thromboangiitis obliterans (TAO) is a type of systemic vasculitis. A high level of IL-33 and its soluble decoy receptor sST2 in the acute phase of systemic vasculitis has been demonstrated. METHODS: The serum level of IL-33 and sST2 in 50 TAO patients, 20 age- and smoking habit-matched controls and 19 age-matched non-smoker controls was evaluated. RESULTS: The mean level of IL-33 in TAO, smokers and non-smokers was 370.2±61.7ng/mL,132.14±2.6ng/mL and 11.3±0.38ng/mL, respectively. The IL-33 was significantly higher in the TAO than in either control groups (p < 0.001). The IL-33 in the acute phase of TAO was significantly higher than in the patients in the quiescent phase of the disease (p = 0.019). Also, IL-33 in the patients with gangrene was significantly higher than in the patients with non-healing ulcers (p = 0.021). The sST2 in the TAO patients was 49.3±5.58ng/mL, and in smoker and non-smoker controls, it was 45.3±6.3ng/mL and 4.11±0.17ng/mL, respectively. No significant difference was found between the patients and smoker control groups (p = 0.87). The mean ratio of IL-33/sST2 was 27.89±10.44 in the TAO group and, in smokers and non-smokers, it was 2.85±0.48 and 2.84±0.14, respectively. A significantly high level of IL-33/sST2 ratio was observed in TAO patients in both the active and quiescent phases of the disease in comparison to both control groups (p<0.001). CONCLUSION: The regulation pattern of IL-33/sST2 was different in TAO in comparison to autoimmune vasculitis.
format Online
Article
Text
id pubmed-7371438
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-73714382020-08-05 The IL-33/sST2 Axis in Thromboangiitis Obliterans Sharebiani, Hiva Mohareri, Mehran Mirhosseini, Ali Fazeli, Bahare J Inflamm Res Original Research BACKGROUND: Until recently, it remains unknown whether thromboangiitis obliterans (TAO) is a type of systemic vasculitis. A high level of IL-33 and its soluble decoy receptor sST2 in the acute phase of systemic vasculitis has been demonstrated. METHODS: The serum level of IL-33 and sST2 in 50 TAO patients, 20 age- and smoking habit-matched controls and 19 age-matched non-smoker controls was evaluated. RESULTS: The mean level of IL-33 in TAO, smokers and non-smokers was 370.2±61.7ng/mL,132.14±2.6ng/mL and 11.3±0.38ng/mL, respectively. The IL-33 was significantly higher in the TAO than in either control groups (p < 0.001). The IL-33 in the acute phase of TAO was significantly higher than in the patients in the quiescent phase of the disease (p = 0.019). Also, IL-33 in the patients with gangrene was significantly higher than in the patients with non-healing ulcers (p = 0.021). The sST2 in the TAO patients was 49.3±5.58ng/mL, and in smoker and non-smoker controls, it was 45.3±6.3ng/mL and 4.11±0.17ng/mL, respectively. No significant difference was found between the patients and smoker control groups (p = 0.87). The mean ratio of IL-33/sST2 was 27.89±10.44 in the TAO group and, in smokers and non-smokers, it was 2.85±0.48 and 2.84±0.14, respectively. A significantly high level of IL-33/sST2 ratio was observed in TAO patients in both the active and quiescent phases of the disease in comparison to both control groups (p<0.001). CONCLUSION: The regulation pattern of IL-33/sST2 was different in TAO in comparison to autoimmune vasculitis. Dove 2020-07-16 /pmc/articles/PMC7371438/ /pubmed/32765040 http://dx.doi.org/10.2147/JIR.S253980 Text en © 2020 Sharebiani et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Sharebiani, Hiva
Mohareri, Mehran
Mirhosseini, Ali
Fazeli, Bahare
The IL-33/sST2 Axis in Thromboangiitis Obliterans
title The IL-33/sST2 Axis in Thromboangiitis Obliterans
title_full The IL-33/sST2 Axis in Thromboangiitis Obliterans
title_fullStr The IL-33/sST2 Axis in Thromboangiitis Obliterans
title_full_unstemmed The IL-33/sST2 Axis in Thromboangiitis Obliterans
title_short The IL-33/sST2 Axis in Thromboangiitis Obliterans
title_sort il-33/sst2 axis in thromboangiitis obliterans
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371438/
https://www.ncbi.nlm.nih.gov/pubmed/32765040
http://dx.doi.org/10.2147/JIR.S253980
work_keys_str_mv AT sharebianihiva theil33sst2axisinthromboangiitisobliterans
AT moharerimehran theil33sst2axisinthromboangiitisobliterans
AT mirhosseiniali theil33sst2axisinthromboangiitisobliterans
AT fazelibahare theil33sst2axisinthromboangiitisobliterans
AT sharebianihiva il33sst2axisinthromboangiitisobliterans
AT moharerimehran il33sst2axisinthromboangiitisobliterans
AT mirhosseiniali il33sst2axisinthromboangiitisobliterans
AT fazelibahare il33sst2axisinthromboangiitisobliterans